s.demir

TL2 Moderator · Tours

Contributes reviews on supplier material. Based in Tours.

Joined 8 February 2025 · last posted 2d

94 posts, newest first. Showing up to 150.

What to bring: records that a clinician can actually use — a second dataset Replied, post #79 · Clinical › Prescriber conversations · 26 Jul 2026 · 6 likes This follows post #76 rather than contradicting it. What to bring: copies of relevant lab results, pharmacy records (to confirm doses actually taken), and records of…
Rotating between abdomen, thigh and upper arm: absorption differences — one year on Replied, post #101 · Practice › Administration · 24 Jul 2026 · 13 likes Cold solution and stinging: warming the vial in your hands for a minute before injection reduces the stinging sensation substantially. This is the simplest thing to try…
Coming back to: Solubility limits and what a cloudy solution is telling you Replied, post #43 · Pharmacology › Formulation chemistry · 24 Jul 2026 · 21 likes Emulsification and suspensions: some formulations are emulsions or suspensions rather than solutions. Semaglutide formulations are solutions; some other compounds are…
Impurity thresholds: where the common numbers come from Replied, post #10 · Analytics › Impurities & related substances · 20 Jul 2026 · 22 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
What is genuinely unknown about long-term amylin agonism Replied, post #53 · Compounds › Cagrilintide & amylin analogues · 18 Jul 2026 · 23 likes The CagriSema phase 2 paper: a fixed combination of the two components in one weekly injection. The trade-off of a fixed combination is that you cannot titrate the…
Follow-up: Prior authorisation: what the criteria usually require Replied, post #79 · Access › Insurance & coverage · 17 Jul 2026 · 16 likes post #78 answers the question as asked. The question underneath it is different. Denial letters: the stated reason tells you exactly what to submit next. A denial is…
Coming back to: A structured critique template this community uses Replied, post #60 · Evidence › Study critique · 16 Jul 2026 · 27 likes Building consensus on which criticisms matter: if everyone agrees that the sample size is small but only you think that affects the conclusion, maybe your criticism is…
Coming back to: Time to steady state after a dose increase Replied, post #99 · Pharmacology › Pharmacokinetics · 12 Jul 2026 · 16 likes Fasting requirement for oral semaglutide: food and large fluid volumes reduce absorption. The fasting window (30 minutes before and 30 minutes after) is designed to…
Tirzepatide storage and stability: what is published versus what is assumed Replied, post #8 · Compounds › Tirzepatide · 12 Jul 2026 · 21 likes Worth separating two things that post #4 runs together. Dual agonism versus dose: how much of tirzepatide's effect is the GIP component and how much is simply achieving…
Stepping down deliberately, and how to do it without losing progress — what changed since Replied, post #51 · Practice › Dosing & titration · 9 Jul 2026 · 0 likes Coming back to post #49, because the follow-up matters more than the original answer. The arithmetic of an intermediate dose: if the label says 1.0 mg and 2.0 mg, a…
A critique that turned out to be unfair, retracted by its author Replied, post #23 · Evidence › Study critique · 3 Jul 2026 · 0 likes Bias towards the null and bias away from the null: different criticisms have different directions. Differential dropout might bias away from null; conservative…
A 40-week log with the measurement method stated — what changed since Replied, post #10 · Outcomes › Progress reports · 30 Jun 2026 · 0 likes Plateaus and resets: if weight loss stalls and then resumes, that is ordinary. It is not evidence that the medication stopped working. It is not evidence that it is…
Journal club: what we got wrong in an earlier session Replied, post #23 · Evidence › Journal club · 23 Jun 2026 · 30 likes This follows post #20 rather than contradicting it. TRIUMPH (ongoing): Retatrutide phase 3. No results yet. Nothing should be attributed to it because it has not…
Follow-up: Reading an interaction checker output critically Replied, post #14 · Practice › Interactions · 22 Jun 2026 · 10 likes Worth separating two things that post #10 runs together. Food interactions: most interactions are absorption interactions. Some medications absorb better with food,…
Sample size intuition for a personal experiment — does this still hold? Replied, post #33 · Research Methods › Statistics · 16 Jun 2026 · 26 likes post #32 answers the question as asked. The question underneath it is different. Number needed to treat: how many people need to be treated to prevent one bad outcome…
Tracking a shortage from primary sources rather than rumour Replied, post #48 · Access › Shortages · 12 Jun 2026 · 15 likes This follows post #45 rather than contradicting it. Patient advocacy during shortages: some advocacy groups advocate for patients during shortages. Knowing who they are…
Why cagrilintide alone is discussed so much less than in combination — does this still… Replied, post #7 · Compounds › Cagrilintide & amylin analogues · 11 Jun 2026 · 1 like This follows post #4 rather than contradicting it. Cagrilintide alone is discussed less than in combination because the published data is almost entirely from…
Tracking a shortage from primary sources rather than rumour — the long version Started this topic · Access › Shortages · 4 Jun 2026 · 2 likes On the subject in the title: Tracking a shortage from primary sources rather than rumour — the long version Working notes rather than a conclusion. Documenting an…
Revisiting: Mobile reading experience on long topics Replied, post #7 · Meta › Site feedback · 23 May 2026 · 1 like Picking up post #4: that is the part I would want checked first. Search and findability: if you searched for something and did not find it, report what you searched for…
Personal or family history of medullary thyroid carcinoma — what changed since Replied, post #48 · Safety › Contraindications · 23 May 2026 · 9 likes Disordered eating history: appetite suppression can trigger relapse in people with history of anorexia, bulimia, or other eating disorders. This is a relative…
Prescription requirements and telehealth models — a second dataset Replied, post #21 · Sourcing › Regulatory · 6 May 2026 · 3 likes post #20 is right about the mechanism and I think understates the practical bit. Thank you for the correction. I have edited my earlier post with a note rather than…
Revisiting: A field-by-field walk through a certificate of analysis Replied, post #36 · Analytics › COA interpretation · 4 May 2026 · 2 likes Endotoxin testing is separate: a certificate of purity says nothing about endotoxin. A chemically pure preparation can carry a clinically significant endotoxin load. If…
Coming back to: Lateral-flow and colorimetric approaches: the specificity problem Replied, post #9 · Analytics › Home & field testing · 26 Apr 2026 · 1 like Picking up post #6: that is the part I would want checked first. Immunoassay limitations: tests that use antibodies have cross-reactivity limitations. An antibody…
Severe abdominal pain: why this is not a forum question Replied, post #3 · Safety › Adverse events · 25 Apr 2026 · 0 likes Allergic reactions: true allergy (anaphylaxis, severe rash) is rare with these peptide compounds but possible. Distinguishing true allergy from GI intolerance matters.
[2026 update] Charge states for a 4 kDa peptide, worked through Replied, post #104 · Analytics › Mass spectrometry · 22 Apr 2026 · 4 likes Purity and identity are different questions: LC-MS establishes that the species at a retention time has the expected mass. It does not establish how much of the sample…
Anaesthesia and elective surgery: the aspiration question Replied, post #95 · Practice › Interactions · 21 Apr 2026 · 29 likes Sulfonylureas and meglitinides: these agents stimulate insulin release and carry hypoglycemia risk. Combining them with semaglutide or tirzepatide requires dose…
Subgroup analyses: pre-specified versus discovered — a second dataset Replied, post #54 · Evidence › Trials · 21 Apr 2026 · 17 likes Risk of bias: structured appraisal of internal validity. Key things to assess: randomisation method (was it truly random or could someone predict the next assignment),…
[2026 update] Storing lyophilised material long term: what governs the shelf life Replied, post #102 · Practice › Storage & stability · 21 Apr 2026 · 9 likes Beyond-use dating: the date after which a prepared solution should not be used. It is an estimate based on how fast the solution degrades under stated storage, not on…
Price changes over 2025 and 2026, tabulated and dated — does this still hold? Replied, post #144 · Access › Pricing · 12 Apr 2026 · 17 likes Coming back to post #142, because the follow-up matters more than the original answer. Cost per milligram is the only comparison that survives format differences, but…
Publication bias detection and its low power — does this still hold? Replied, post #23 · Evidence › Meta-analyses · 12 Apr 2026 · 0 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
Bug report: the reconstitution calculator and a rounding edge case Replied, post #59 · Data & Tools › Calculators · 9 Apr 2026 · 0 likes Why calculators are not medical advice: they do arithmetic. Medical decisions are not arithmetic. A calculator that says a certain dose is "compatible with" a certain…
Introducing myself: pharmacist, sceptic, reluctant participant — one year on Replied, post #92 · Lounge › Introductions · 17 Mar 2026 · 31 likes This follows post #89 rather than contradicting it. Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still…
Second pass at: Adsorptive losses at low concentration, and why dilute solutions are… Replied, post #57 · Practice › Storage & stability · 7 Mar 2026 · 25 likes I read post #55 twice before replying, because I had assumed the opposite. Two things before anyone answers the substance. First, the context in the first post is clear…
Dizziness on standing and the electrolyte explanation — does this still hold? Replied, post #50 · Practice › Side effects · 26 Feb 2026 · 26 likes Delayed gastric emptying: the mechanism behind much of the gastrointestinal side-effect profile. At extreme magnitudes, severe gastroparesis is a rare but serious…
Pharmacy supply in the UK and the questions you will be asked Replied, post #50 · Regional › UK & Ireland · 21 Feb 2026 · 10 likes Cross-border arrangements: some people source from other EU countries. Rules on import for personal use are changing post-Brexit. Current status requires checking with…
Semaglutide half-life: where the 165 to 184 hour figure comes from Replied, post #122 · Compounds › Semaglutide · 18 Feb 2026 · 1 like The C-cell question: semaglutide triggered medullary thyroid carcinoma in rodent toxicology studies. A signal in rodents does not automatically appear in humans, but it…
[2026 update] Long-time reader, first-time poster Replied, post #51 · Lounge › Introductions · 16 Feb 2026 · 3 likes No spam: introductions are not a place to advertise commercial products or services. That is a rules violation.
Heterogeneity as information rather than as a nuisance Replied, post #90 · Evidence › Meta-analyses · 5 Feb 2026 · 3 likes On post #86 — agreed on the reasoning, with one qualification. Funnel plots: a plot of study effect size versus sample size that helps detect publication bias. If small…
Distinguishing expected GI effects from something that needs urgent attention Replied, post #13 · Practice › Side effects · 1 Jan 2026 · 10 likes Picking up post #10: that is the part I would want checked first. Thank you for the correction. I have edited my earlier post with a note rather than silently, so the…
[2026 update] Evidence quality in the secretagogue literature: an honest assessment Started this topic · Compounds › Secretagogues & GH axis · 14 Dec 2025 · 3 likes Posting this under the heading it deserves: Evidence quality in the secretagogue literature: an honest assessment Everything below is what sits behind that. Comparing…
How to read a forest plot, properly, from scratch Replied, post #60 · Evidence › Trials · 24 Nov 2025 · 12 likes Generalisability: the enrolled population was selected in ways that matter. Entry criteria, run-in periods, and the simple fact that people who agree to a multi-year…
Adolescents: a distinct evidence base — one year on Replied, post #36 · Clinical › Special populations · 21 Nov 2025 · 3 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
Liver enzymes drifting down and what that usually means Replied, post #29 · Clinical › Bloodwork · 20 Nov 2025 · 0 likes Biological variation: the person-to-person variation in a biomarker for a healthy person is larger than most people realize. Comparing your result to the reference…
What a purity-only report leaves out Replied, post #90 · Sourcing › Independent verification · 17 Nov 2025 · 0 likes Service differences on vendor pages: Janoshik and Medutest results are measurements on vials. PeptideMeter verification records are assessments maintained over time.…
Coming back to: Feature request: should a dose-equivalence tool exist at all? Replied, post #7 · Data & Tools › Calculators · 13 Nov 2025 · 27 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
Where the integrator drew the baseline, and how much it moved the number Replied, post #16 · Analytics › HPLC & UHPLC · 27 Oct 2025 · 0 likes Before anything else: what was the gradient, and at what wavelength? Area percent at different wavelengths is not the same number even on the same sample because…
SURMOUNT-4 and what withdrawal data does and does not tell an individual — one year on Replied, post #134 · Compounds › Tirzepatide · 25 Oct 2025 · 0 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
What happens after your first post: likes, trust levels, and why none of it matters much… Replied, post #85 · Start Here › Welcome · 20 Oct 2025 · 3 likes On post #81 — agreed on the reasoning, with one qualification. The FAQ link in the sidebar is maintained and worth ten hours of forum browsing. It is not comprehensive…
Detection wavelength and why 214 nm and 280 nm disagree Replied, post #66 · Analytics › HPLC & UHPLC · 18 Oct 2025 · 2 likes On post #62 — agreed on the reasoning, with one qualification. Peak purity: a diode-array detector records a spectrum at every time point. If a peak contains two…
Lyophilisation and why the cake looks the way it does Replied, post #18 · Pharmacology › Formulation chemistry · 29 Sep 2025 · 0 likes post #17 answers the question as asked. The question underneath it is different. Lyophilisation and reconstitution: the powder is stable for extended periods if kept…
Reverse causation in a cohort study of weight and outcome — a second dataset Replied, post #107 · Evidence › Study critique · 16 Sep 2025 · 9 likes Picking up post #104: that is the part I would want checked first. When you change your mind: if a reply convinces you that your criticism was not well-founded, say so…
[2026 update] Does dual agonism explain the effect size, or is it dose? Replied, post #19 · Compounds › Tirzepatide · 13 Sep 2025 · 21 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
Second pass at: Programming during a large energy deficit Started this topic · Nutrition & Training › Resistance training · 4 Sep 2025 · 0 likes On the subject in the title: Second pass at: Programming during a large energy deficit Working notes rather than a conclusion. Longitudinal report with the method…
Fatigue in the first month: how much is the drug and how much is intake — what changed… Replied, post #58 · Practice › Side effects · 28 Aug 2025 · 22 likes Delayed gastric emptying: the mechanism behind much of the gastrointestinal side-effect profile. At extreme magnitudes, severe gastroparesis is a rare but serious…
The "under review" status pill and when a moderator applies it — a second dataset Replied, post #42 · Evidence › Preprints · 24 Aug 2025 · 21 likes Peer review as a filter: published papers have survived a review process that rejects many submissions. Preprints have not. Neither guarantees correctness, but…
Anxiety in the first weeks: drug, situation, or both — what changed since Replied, post #17 · Wellbeing › Mental health · 19 Aug 2025 · 25 likes Picking up post #14: that is the part I would want checked first. Support and community: some people process weight change through community (online or in-person).…
Revisiting: Why a compound being unapproved is not the same as being illegal to possess Replied, post #81 · Sourcing › Regulatory · 16 Aug 2025 · 0 likes This follows post #78 rather than contradicting it. Research-use-only status is a legal classification, not a safety classification. It means the compound is sold for…
Which panel is worth repeating and which is worth ignoring Replied, post #81 · Clinical › Bloodwork · 10 Aug 2025 · 1 like Worth separating two things that post #77 runs together. Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather…
Are there stupid questions here? A staff answer, at length Replied, post #53 · Start Here › Welcome · 8 Aug 2025 · 1 like Introducing yourself is fine and requires no question. Post in this subcategory, describe the context that matters for why you are here, and lurk for a bit before…
Coming back to: When "no data" is the complete and final answer Replied, post #76 · Compounds › Other compounds · 8 Aug 2025 · 5 likes Coming back to post #74, because the follow-up matters more than the original answer. Melanocortin agonists: mechanism involves the melanocortin-4 receptor pathway that…
Travel coolers and how long they really hold Replied, post #58 · Devices › Cold chain · 5 Aug 2025 · 0 likes Reconstituted solutions: once reconstituted, solutions are less stable than lyophilised powder. Refrigerate prepared solutions immediately after preparation. Most…
[2026 update] What we do not know about retatrutide, listed explicitly Replied, post #24 · Compounds › Retatrutide · 26 Jul 2025 · 5 likes How to read phase 2 without treating it as phase 3: phase 2 establishes that a dose range produces an effect and is tolerable enough to justify large trials. It does…
Titles that describe the question, not the situation Replied, post #51 · Start Here › How to Ask · 18 Jul 2025 · 0 likes Arithmetic questions: write out the steps. "I have a 10 mg vial, I added 2 mL, I want a 0.25 mg dose, and I get this number for the syringe mark" is answerable. "How…
Coming back to: Nausea profile of amylin analogues compared with GLP-1 agonists Replied, post #26 · Compounds › Cagrilintide & amylin analogues · 8 Jul 2025 · 0 likes What is genuinely unknown about long-term amylin agonism: real-world response rates, whether effect is durable with continued use, whether satiety adaptation occurs…
An emergency department visit, described afterwards Replied, post #35 · Safety › Adverse events · 26 Jun 2025 · 0 likes This follows post #32 rather than contradicting it. For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add…
Asking about a compound your prescriber has not heard of Replied, post #73 · Clinical › Prescriber conversations · 22 Jun 2025 · 3 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
Forced degradation studies: designing one that is informative — does this still hold? Replied, post #21 · Analytics › Method validation · 22 Jun 2025 · 2 likes Precision and repeatability: within-run and between-run variability of the method. Acceptance criterion is typically a relative standard deviation of ≤2% for area…
[2026 update] US compounding rules and how they changed Replied, post #20 · Regional › North America · 20 Jun 2025 · 29 likes On post #16 — agreed on the reasoning, with one qualification. Private insurance gaps: some people have private insurance but medication is not covered. Manufacturer…
A 5 mg vial and a 0.25 mg dose: the arithmetic in full — the long version Replied, post #132 · Practice › Reconstitution · 11 Jun 2025 · 0 likes Coming back to post #130, because the follow-up matters more than the original answer. Reconstituting a multi-strength kit: if a kit contains 5 mg, 10 mg, 15 mg vials…
A supplier that answers analytical questions with restated claims Replied, post #83 · Sourcing › Red flags · 25 May 2025 · 12 likes Unresponsiveness: a supplier that does not reply to reasonable requests for documentation or clarification is showing you something about how they operate.
TB-500 and thymosin beta-4: the fragment versus the protein Replied, post #21 · Compounds › Repair & healing peptides · 24 May 2025 · 12 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
A well-designed study with a badly written abstract Replied, post #51 · Evidence › Study critique · 29 Apr 2025 · 22 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
[2026 update] What the GIP component of tirzepatide is thought to contribute, and how… Replied, post #38 · Compounds › Tirzepatide · 12 Apr 2025 · 23 likes SURMOUNT-4 used a randomised withdrawal design: everyone titrated, then those on maintenance were randomised to continue or placebo. Continuation maintained effect;…
An orphaned page with no inbound links Replied, post #7 · Meta › Wiki maintenance · 9 Feb 2025 · 0 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
Isotope patterns and why the monoisotopic peak is not the tallest Replied, post #10 · Analytics › Mass spectrometry · 11 Jan 2025 · 10 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
[2026 update] New subcategory: rationale and scope Replied, post #127 · Meta › Announcements · 7 Jan 2025 · 33 likes Picking up post #124: that is the part I would want checked first. Scheduled maintenance: if the site is going offline for maintenance, advance notice will be posted…
Revisiting: Bug report: the reconstitution calculator and a rounding edge case Replied, post #28 · Data & Tools › Calculators · 24 Dec 2024 · 33 likes Storage lookup: which conditions (temperature, time) are you considering storing in, and how much stability loss is expected? The calculator gives a rough estimate…
Building a sensible monitoring schedule with your prescriber Replied, post #23 · Clinical › Bloodwork · 19 Dec 2024 · 6 likes Time of day: some biomarkers vary across the day. Cortisol in the morning differs from cortisol in the evening. Comparing results from different times of day is…
Type 1 diabetes: off-label use and the evidence gap — what changed since Replied, post #5 · Clinical › Special populations · 19 Nov 2024 · 6 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
US compounding rules and how they changed Replied, post #69 · Regional › North America · 12 Nov 2024 · 6 likes I read post #67 twice before replying, because I had assumed the opposite. Practical note that does not fit anywhere else. Whatever you conclude from this topic, write…
Choosing which test to pay for, given a fixed budget — does this still hold? Replied, post #11 · Sourcing › Independent verification · 27 Oct 2024 · 0 likes post #10 answers the question as asked. The question underneath it is different. Interpreting a result: a purity figure is one measurement on one vial on one day.…
Irish differences from the UK position Replied, post #53 · Regional › UK & Ireland · 23 Oct 2024 · 0 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
Why I ask for the gradient before I discuss the number Replied, post #27 · Analytics › HPLC & UHPLC · 12 Oct 2024 · 0 likes Worth separating two things that post #23 runs together. Reversed-phase separates on hydrophobicity. A peptide is retained on a non-polar stationary phase and eluted by…
Revisiting: How to bring a laboratory report to an appointment usefully Replied, post #95 · Clinical › Bloodwork · 9 Oct 2024 · 0 likes Analytical imprecision: any measurement has an error margin. A small difference in consecutive tests is usually measurement noise, not a real change. Knowing the…
Semaglutide half-life: where the 165 to 184 hour figure comes from — what changed since Replied, post #14 · Compounds › Semaglutide · 22 Sep 2024 · 25 likes post #13 answers the question as asked. The question underneath it is different. Thank you for the correction. I have edited my earlier post with a note rather than…
Semaglutide in people without diabetes: what the evidence base looks like Replied, post #2 · Compounds › Semaglutide · 17 Sep 2024 · 0 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
Pen wastage and its effect on real cost Replied, post #23 · Access › Pricing · 9 Sep 2024 · 0 likes Compute cost per delivered dose at your dose if you want a number you can act on. That requires knowing your dose, vial volume, and whether you are using a vial or a pen.
Progressive overload when the scale is falling — one year on Replied, post #11 · Nutrition & Training › Resistance training · 28 Aug 2024 · 1 like post #10 is right about the mechanism and I think understates the practical bit. Adaptation and plateau: if strength does not change for weeks, that is stability, not…
Correlation in a self-tracked dataset: what it can support Replied, post #143 · Research Methods › Statistics · 25 Aug 2024 · 2 likes post #142 answers the question as asked. The question underneath it is different. Number needed to treat: how many people need to be treated to prevent one bad outcome…
Reporting a discrepancy without making an allegation Replied, post #13 · Sourcing › Vendor reports · 3 Aug 2024 · 0 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
Follow-up: Where the four-week escalation interval comes from, and what it is not Replied, post #38 · Practice › Dosing & titration · 3 Aug 2024 · 0 likes The four-week escalation interval is a convention from the pivotal trials, not a pharmacological constant. The pharmacological argument is that with a week-long…
The mass-error checker and its intended scope Replied, post #146 · Data & Tools › Calculators · 23 Jul 2024 · 4 likes On post #142 — agreed on the reasoning, with one qualification. Reporting bugs: if you notice a calculator giving wrong results, report it in this subcategory. Bugs are…
Reading a meta-analysis you disagree with, fairly Replied, post #5 · Evidence › Meta-analyses · 14 Jul 2024 · 27 likes Pooled estimates and heterogeneity: when trials differ in population, duration, or comparator, a pooled estimate answers a question that no individual trial asked. High…
Two sessions a week versus four: what the evidence supports — a second dataset Replied, post #15 · Nutrition & Training › Resistance training · 21 Jun 2024 · 21 likes Frequency: three sessions per week of full-body training is easier to maintain than higher frequencies on an energy deficit. Consistency beats intensity when recovery…